Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.Treasury futures closed in early trading, with the main contract of 2-year Treasury futures (TS) falling by 0.06%, 5-year Treasury futures (TF) falling by 0.13%, 10-year Treasury futures (T) falling by 0.15% and 30-year Treasury futures (TL) falling by 0.26%.Thai Ministry of Finance: State-owned banks will lend 1 trillion baht to support economic development.
The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 51st consecutive trading day, which was 380 billion less than that of the previous trading day.Will the air ticket price in the United States rise in November? Goldman Sachs and Bank of America have their own opinions. Due to the rising cost of housing, insurance and medical services, the core inflation rate in the United States has remained high. Second-hand car prices may rise due to the rebound of auction prices, but economists are still divided on whether the increase in air ticket prices will become a reality. Goldman Sachs predicts that air ticket prices will increase by 1% month-on-month, reflecting a strong potential pricing trend. Bank of America, on the other hand, said, "We expect the air ticket price to drop by 1% month-on-month, which will change the contribution rate of core inflation from +3 basis points to -1 basis point. Due to the decline in air ticket prices, the monthly core inflation rate will drop to 0.2%, but the volatility of this category is still very large. "Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.
China made more than half of the imported cars registered in South Korea in November. According to a data released by CARISYOU, a Korean automobile data research institution, the proportion of Chinese-made cars registered in South Korea in November was 54.3%, setting a record this year. The data shows that there were 659 newly registered imported cars in November, of which 358 were made in China, accounting for 54.3%, setting a record for the highest proportion in a single month this year. By brand, BYD increased by 21.7% year-on-year to 140 vehicles, ranking first among all imported car brands. Brands such as Geely (No.3), Xinyuan (No.4), Haig School Bus (No.8) and Dongfeng Xiaokang (No.10) are also among the top ten. The number and proportion of Chinese-made cars registered in Hanxin increased year by year, with only 296 (6.2%) in 2020, 569 (9.9%) in 2021, 2276 (29%) in 2022 and 4215 (47.5%) in 2023.Beijing Stock Option Pioneer Venture Capital Fund was registered and established with a capital contribution of 100 million yuan. According to Tianyancha App, recently, the Stock Option Pioneer Venture Capital Fund (Limited Partnership) was established. The executive partner is Beijing Zhongguancun Capital Fund Management Co., Ltd., with a capital contribution of 100 million yuan. Its business scope is venture capital, and private equity funds are engaged in equity investment, investment management, asset management and other activities. According to the partner information, the fund is jointly funded by Beiyin Wealth Management Co., Ltd., Beijing Zhongguancun Capital Fund Management Co., Ltd. and Beijing Harmony Jiarui Investment Management Co., Ltd.The three departments issued the tax policy on the transformation of operating cultural institutions into enterprises in the cultural system reform, and the Ministry of Finance, the State Administration of Taxation and the Central Propaganda Department issued the Announcement on the Tax Policy on the Transformation of Operating Cultural Institutions into Enterprises in the Cultural System Reform, which mentioned that operating cultural institutions can enjoy the following transitional tax preferential policies: if operating cultural institutions are transformed into enterprises before December 31, 2022, they will be exempted from enterprise income tax from the date of registration of transformation to December 31, 2027. If a cultural unit funded by the financial department is transformed into an enterprise before December 31, 2022, its self-use property will be exempted from property tax from the date of registration of transformation to December 31, 2027.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide